We are excited to announce Jon Garen as our Chief Business Officer. Jon brings more than 25 years of operational experience in business development, and pipeline and corporate strategy to Dunad- check out the full press release on our website: https://lnkd.in/eNyApHWf #lifesciencesindustry #biopharma #leadership #dunadtx
Dunad Therapeutics’ Post
More Relevant Posts
-
Proud to be featured by Rapid Cloud Partners, Inc. as a client success story! #rapidcloudpartners #dunadtx #biotech
Client Success Story: Dunad Therapeutics Implements NetSuite OneWorld Dunad Therapeutics Streamlines Finance Operations and Reporting “Rapid Cloud Partners helped us implement NetSuite OneWorld, leading to streamlined procedures and real-time, unified global reporting. We now have a better understanding of spending by program across multiple entities and have reduced our month end close by one week." - Holly Whittemore, COO Rapid Cloud Partners helped Dunad Therapeutics implement NetSuite OneWorld to meet its comprehensive global accounting needs. The implementation emphasized key areas such as the general ledger, purchasing, accounts payable, and tax compliance. A critical aspect of the system's design was tracking of program expenditures, covering everything from planning and purchase commitments to actual expenses. By collaborating closely with the accounting departments in the US and UK, Rapid Cloud Partners successfully implemented the system in less than four months. This implementation led to the discontinuation of two Xero accounting system instances, thereby standardizing operations worldwide. NetSuite also consolidates the results automatically, eliminating the need for a time-consuming, Excel-based process. To read more about this transformational project, please see our blog at: https://lnkd.in/dsEZ5zxb #rapidcloudpartners #dunadtx #netsuiteoneworld #biotech
-
-
Dunad Therapeutics is excited to participate in the inaugural Covalent Drug Discovery Summit 2023 in Boston this week, including a Panel Discussion led by Dr. Laura Akullian D'Agostino, VP Chemistry, featuring our CSO Dr. Ruben Tommasi. The session is “Identifying the Most Promising Hits to Advance Lead Optimization” - come and see us today at 2:15pm! https://lnkd.in/dAbnydns
-
-
Dunad Therapeutics is delighted to be showcased as one of the 50 companies in PwC UK's 'Life Sciences Future 50' report, illustrating the world-class science and innovation being led by the UK’s life sciences sector to solve some of the most important challenges in scientific research and human healthcare. Find out more here: https://bit.ly/3Fnw379 #LifeSciences #BioTech #DigitalHealth #PwCFuture50
-
-
We are delighted to announce our CEO Pearl Huang has been awarded Biotech Week Boston’s Lifetime Achievement Award. This recognition is a testament to Pearl’s leadership and success in the biotech and pharma industries over the past 30 years. We are fortunate to have her at the helm as we continue to expand the frontier of protein degradation to create transformational medicines.
-
-
Dunad Therapeutics is thrilled to announce that CEO Pearl Huang has been selected as a finalist for the Lifetime Achievement Award at Biotech Week Boston 2023! The Lifetime Achievement Award recognizes an exceptional individual who has served the industry beyond the call of duty throughout a distinguished career. For the last 30 years Pearl Huang has been doing just that by applying her strong leadership, scientific and business insights to bring innovative therapies to patients in need.
-
